JP2009511547A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511547A5
JP2009511547A5 JP2008535026A JP2008535026A JP2009511547A5 JP 2009511547 A5 JP2009511547 A5 JP 2009511547A5 JP 2008535026 A JP2008535026 A JP 2008535026A JP 2008535026 A JP2008535026 A JP 2008535026A JP 2009511547 A5 JP2009511547 A5 JP 2009511547A5
Authority
JP
Japan
Prior art keywords
imidazol
methanone
phenyl
biphenyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008535026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/067315 external-priority patent/WO2007042546A1/en
Publication of JP2009511547A publication Critical patent/JP2009511547A/ja
Publication of JP2009511547A5 publication Critical patent/JP2009511547A5/ja
Abandoned legal-status Critical Current

Links

JP2008535026A 2005-10-14 2006-10-12 不安及び関連疾患の治療のためのイミダゾール誘導体 Abandoned JP2009511547A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200501445 2005-10-14
US72667705P 2005-10-17 2005-10-17
PCT/EP2006/067315 WO2007042546A1 (en) 2005-10-14 2006-10-12 Imidazole derivatives for the treatment of anxiety and related diseases

Publications (2)

Publication Number Publication Date
JP2009511547A JP2009511547A (ja) 2009-03-19
JP2009511547A5 true JP2009511547A5 (https=) 2009-10-15

Family

ID=37441005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008535026A Abandoned JP2009511547A (ja) 2005-10-14 2006-10-12 不安及び関連疾患の治療のためのイミダゾール誘導体

Country Status (6)

Country Link
US (1) US8030339B2 (https=)
EP (1) EP1937649A1 (https=)
JP (1) JP2009511547A (https=)
AU (1) AU2006301222A1 (https=)
CA (1) CA2625974A1 (https=)
WO (1) WO2007042546A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8937184B2 (en) * 2005-02-16 2015-01-20 Abbvie B.V. 1H-imidazole derivatives as cannabinoid CB2 receptor modulators
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
MX2010014066A (es) * 2008-06-16 2011-06-01 Univ Tennessee Res Foundation Compuestos para el tratamiento del cancer.
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
WO2010034927A1 (fr) * 2008-09-24 2010-04-01 Zach System Procede de preparation de nebivolol
US8343976B2 (en) 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物
WO2013120771A1 (en) * 2012-02-13 2013-08-22 F. Hoffmann-La Roche Ag Imidazolylketone derivatives asd aldosterone synthase inhibitors
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類
PE20230413A1 (es) * 2020-04-03 2023-03-07 Veru Inc Metodos de tratamiento del coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3627155A1 (de) * 1986-08-11 1988-02-18 Schering Ag Imidazol-derivate
AU2003245259A1 (en) * 2002-05-02 2003-11-17 Neurogen Corporation Substituted imidazole derivatives: gabaa receptor ligands
WO2004041809A2 (en) * 2002-05-08 2004-05-21 Neurogen Corporation Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands

Similar Documents

Publication Publication Date Title
JP2009511547A5 (https=)
RU2386620C2 (ru) Производные пиридазин-3(2н)-она и их применение в качестве ингибиторов фдэ4
DE69528273T2 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
CN101679287B (zh) 烟碱型乙酰胆碱受体调节剂
AU2017261551B2 (en) Substituted pyrazoles as N-type calcium channel blockers
JP2008539195A (ja) 新規のオキサジアゾール誘導体及びそれらの医学的使用
JP2006525298A5 (https=)
EP2257167A1 (en) 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
JP2015503507A5 (https=)
JP2008513516A5 (https=)
RU2008130448A (ru) Применение производных 4-имидазола для расстройств цнс
JP2009530353A5 (https=)
US12391664B2 (en) GluN2C/D subunit selective antagonists of the N-methyl-D-aspartate receptor
AU2007209381A1 (en) Use of substituted 2-imidazole of imidazoline derivatives
RU2356888C2 (ru) Новые азетидиновые соединения
JP2010524899A5 (https=)
JP2013541513A5 (https=)
CA2770932A1 (en) Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
JP2008533087A5 (https=)
JP2011529943A (ja) CRF1アンタゴニストとしてのピラゾロ[5,1−b]オキサゾール誘導体
JP2006519208A5 (https=)
DE69720428T2 (de) Heterocyclisch substituierte imidazole zur behandlung von entzündungen
JP2007521312A5 (https=)
JP2024542881A5 (https=)
JP2010540628A (ja) カルシウムチャネル遮断薬としてのn−置換されたオキシインドリン誘導体